MedX Health Corp (MDXHF)
MedX Health Corp operates in the Medical - Devices industry of the Healthcare sector, headquartered in Mississauga, ON, CA. The stock last traded at $0.03, up 0.00% on the session, giving a market capitalisation of $8.2M. On trailing twelve-month figures it carries a trailing P/E of -1.84, a net margin of -1085.6%. Its beta of 1.79 implies it has historically moved more than the broad market.
MedX Health Corp is a medical technology company specializing in both diagnostic tools and therapeutic devices. The firm develops, manufactures, and markets advanced solutions for skin screening and light-based therapy, serving customers across Canada, the United States, and international markets. Its diagnostic portfolio includes SIAscopy, a cutting-edge medical device technology designed to scan skin for early detection of suspicious moles and lesions. MedX also offers a suite of imaging systems – SIAMETRICS, SIMSYS, and MoleMate – which provide real-time visuals, allowing physicians and dermatologists to rapidly assess various types of moles and lesions. On the therapeutic side, MedX produces phototherapeutic medical devices. These devices employ low-level laser and LED light energy to address pain relief and promote tissue repair, primarily within the rehabilitation sector. To enhance accessibility, MedX operates the DermSecure telemedicine platform. This web-based system enables the remote operation of its SIAscopy technology, facilitating the deployment of its diagnostic tools in a network of third-party locations. Through DermSecure, patient images of moles and lesions, alongside other relevant clinical data, can be securely transmitted to specialist physicians for expert remote assessment. The company was founded in 1999 and its headquarters are situated in Mississauga, Canada.
MedX Health Corp is most often compared with the following Healthcare names: